1505. Kumar NP, Banurekha VV, Dina N, Babu S. Angiopoietins as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis. Int J Tuberc Lung Dis.2017; 21(1): 93-99.
1506. Kumar NP, Kadar M, Sivakumar S, Menon PA, Vijay V, Kornfeld H, Babu S. Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors. J Infect.2017; 74(1):10-21.
1507. Devaleenal D B, Ramachandran G , Swaminathan S. The challenges of pharmacokinetic variability of first-line anti-TB drugs. Expert Rev Clin Pharmacol. 2017;10(1):47-58.
1508. Anne NS, Ronald BSM, Senthil Kumar TMA, Kannan P, Thangavelu A. Molecular identification of Mycobacterium tuberculosis in cattle . Vetr Microbiol.2017;198:81-87.
1509. Kumar AK , Chandrasekaran V, Kannan T , Murali AL , Lavanya J , Sudha V , Swaminathan S , Ramachandran G. Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus. Eur J Clin Pharmacol .2017;73(1):65-70.
1510. Rao VG , Bhat J, Yadav R, Muniyandi M, Bhondeley MK , Wares DF. Smoking and alcohol consumption: Risk factors for pulmonary tuberculosis among the tribal community in central India. Indian J Tuberc. 2017;64(1):40-43.
1511. Padmapriyadarsini C , Shri Vijay Bala Yogendra S, Joseph B, Lakshmi M. Multidrug resistant tuberculosis during pregnancy. Indian J Tuberc .2017;64(1):63-64.
1512. Anuradha R, Munisankar S, Bhootra Y, Dolla C, Nutman TB, Babu S . Microbial translocation associated with an acute phase response and elevations in MMP-1, HO-1 and pro-inflammatory cytokines in Strongyloides stercoralis infection. I nfect Immun .2016;85(1):e00772-16.
1513. Hemanth Kumar AK , Ramesh K , Kannan T , Sudha V , Haribabu H , Lavanya J , Swaminathan S , Ramachandran G . N-acetyltransferase gene polymorphisms & plasma isoniazid concentrations in patients with tuberculosis. Indian J Med Res.2017;145(1):118-123.
1514. Thiruvalluvan E, Thomas B, Suresh C, Sellappan S, Muniyandi M, Watson B. The psychosocial challenges facing multi drug resistance tuberculosis patients: A qualitative study. SAARCJ TB, Lun Dis HIV/AIDS.2017;XIV(1):14-21.
1515. Hemanth Kumar AK, Sudha V, Ramachandran G. A Simple and rapid liquid chromatography method for determination of levofloxacin in plasma. SAARCJ TB, Lun Dis HIV/AIDS.2017;XIV(1):27-32.
1516. Gokul Raj K, K adar M, Bhaskaran D, G omathi S, Sridhar R, Vidyajayanthi B, Gajendraraj G , Babu S . Reduced systemic and mycobacterial antigen-stimulated concentrations of IL-1ß and IL-18 in tuberculous lymphadenitis. Cytokine. 2017 ; 90:66-72.
1517. Biello KB , Thomas BE, Johnson BE , Closson EF, Navakodi P , Dhanalakshmi A, Menon S, Mayer KH, Safren SA, Mimiaga MJ . Transactional sex and the challenges to safer sexual behaviors: a study among male sex workers in Chennai, India. AIDS Care. 2017;29(2):231-238.
1518. Sambarey A , Devaprasad A , Mohan A , Ahmed A , Nayak S , Swaminathan S , D'Souza G , Jesuraj A , Dhar C , Babu S , Vyakarnam A , Chandra N . Unbiased identification of blood-based biomarkers for pulmonary tuberculosis by modeling and mining molecular interaction networks. EBiomedicine.2017; 15:112-126.
1519. Chandrasekaran K, Kaushik G. Relative risk for HIV in India –An estimate using conditional auto-regressive models with Bayesian approach. Spatial and Spatio-temporal Epid.2017;20:27–34.
1520. Srinivasan R, Ponnuraja C, Rajendran S, Venkatesan P. Spatial Frailty Survival Model for Infection of Tuberculosis among HIV Infected Individuals. SSRG Inter J Med Sci. 2017;4(2):5-10.
1521. Manson AL, Cohen KA, Abeel T, Desjardins CA, Armstrong DT, Barry CE 3rd, Brand J; TBResist Global Genome Consortium., Chapman SB, Cho SN, Gabrielian A, Gomez J, Jodals AM, Joloba M, Jureen P, Lee JS, Malinga L, Maiga M, Nordenberg D, Noroc E, Romancenco E, Salazar A, Ssengooba W, Velayati AA, Winglee K, Zalutskaya A, Via LE, Cassell GH, Dorman SE, Ellner J, Farnia P, Galagan JE, Rosenthal A, Crudu V, Homorodean D, Hsueh PR, Narayanan S, Pym AS, Skrahina A, Swaminathan S, Van der Walt M, Alland D, Bishai WR, Cohen T, Hoffner S, Birren BW, Earl AM. Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance. Nat Genet .2017;49(3):395-402 .
1522. Vidya Vijayan KK, Sameer H, Precilla LK, Ashok Kumar M, Padmapriyadarsini C, Swaminathan S, Hanna LE. Biased nucleotide composition and differential codon usage pattern in HIV-1 and HIV-2. AIDS Res Hum Retroviruses .2017;33(3):298-307.
1523. Anuradha R, Munisankar S, Bhootra Y, Dolla C, Kumaran P, Nutman TB, Babu S . Anthelmintic therapy modifies the systemic and mycobacterial-antigen-stimulated cytokine profile in helminth-latent Mycobacterium tuberculosis co-infection. Infect Immun.2017;85(4).
1524. Ponnuraja C, Lakshmanan BC, Valarmathi S, Krishna Prasanth B. Decision tree classification and model evaluation for breast cancer survivability: A data mining approach. Biomedical & Pharmacol J.2017;10(1):281-289.
1525. Dina N, Banurekha VV , Kannan T, Tripathy JP, Harries AD, Mohan N, Swaminathan S. Predictors of unfavourable treatment outcome in patients with multidrug-resistant tuberculosis in India. Public Health Action.2017;7(1):32-38.
1526. Ramesh Kumar S, Pooranagangadevi N, Rajendran M, Mayer K, Flanigan T, Niaura R, Balaguru S, Venkatesan P, Swaminathan S. Physician's advice on quitting smoking in HIV and TB patients in south India: a randomised clinical trial. Public Health Action.2017;7(1):39-45.
1527. Adinarayanan S, Culp RK, Subramani R, Abbas KM, Radhakrishna S, Swaminathan S. Role of bacille Calmette-Guérin in preventing tuberculous infection. Int J Tuberc Lung Dis.2017; 21(4):420-424.
1528. Narayanaiah C, Precilla LK, Hemalatha B, Vidya Vijayan KK, Ashokkumar M, Padmapriyadasrsini C, Kailasam N, Sundaramurthi JC, Swaminathan S, Buddolla V, Vaniambadi SK, Ramanathan VD, Hanna LE . Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals. Sci Rep.2017;24;7:46557.
1529. Kumar NP, Banurekha VV, Nair D, Babu S . Diminished plasma levels of common ?-chain cytokines in pulmonary tuberculosis and reversal following treatment. PLoS One .2017;12(4):e0176495.
1530. Thulasingam M , Damodharan S , Vigneshwari GM , Pandaranayaka EP , Hanna LE , Usha R , Krishnaswamy S. Characterization of Salmonella typhi OmpC and OmpF porins engineered with HIV-gp41 epitope on the surface loops. Proteins . 2017; 85(4):657-664.
1531. Angeline Grace G, Devaleenal D B , Mohan N. Genital tuberculosis in females. Indian J Med Res.2017;145:425-436.
1532. Hemanth Kumar AK, Chandrasekaran V, Kiran Kumar A, Kawaskar M, Lavanya J, Swaminathan S, Ramachandran G. Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs. Indian J Med Res.2017;145:530-535.
1533. Ramachandran G, Kumar AK, Chandrasekaran V, Kannan T, Vijayalakshmi R, Dusthackeer VN, Ramesh K, Lavanya J, Swaminathan S. Factors influencing tuberculosis treatment outcome in adult patients treated with thrice-weekly regimens in India. Antimicrob Agents Chemother .2017;61(5):e02464-16.
1534. Krishnamoorthy E , Hassan S , Hanna LE , Padmalayam I , Rajaram R , Viswanathan V .
Homology modeling of Homo sapiens lipoic acid synthase: Substrate docking and insights on its binding mode. J Theor Biol. 2017;420:259-266.
1535. Anuradha R , Munisankar S , Bhootra Y , Dolla C , Kumaran P , Nutman TB , Babu S . Modulation of Mycobacterium tuberculosis -specific humoral immune responses is associated with Strongyloides stercoralis co-infection. PLoS Negl Trop Dis. 2017; 11(5):e0005569.
1536. Gokul Raj K, Kadar M, Baskaran D, Banurekha VV, Nair D, Sekar G, Sridhar R, Vidyajayanthi B, Gajendraraj G, Parandhaman DK, Alena S, Babu S . TB lymphadenitis is associated with enhanced baseline and antigen - specific induction of Type 1 and Type 17 cytokines and reduced IL-1ß and IL-18 at the site of infection. Clin Vaccine Immunol.2017; 24( 5): e00045-17.
1537. Anuradha R, Babu S. Determining the Frequencies of Th9 Cells from Whole Blood. Methods Mol Biol. 2017;1585:83-92. Book chapter
1538. Prada-Medina CA , Fukutani KF, Pavan Kumar N, Gil-Santana L, Babu S, Lichtenstein F, West K, Sivakumar S, Menon PA , Viswanathan V, Andrade BB, Nakaya HI, Kornfeld H. Systems Immunology of diabetes-tuberculosis comorbidity reveals signatures of disease complications. Sci Rep. 2017;7(1):1999.
1539. Singh B, Anbalagan S, Selvaraj P. Regulatory role of CCL5 (rs2280789) and CXCL10 (rs56061981) gene polymorphisms on intracellular CCL5 and CXCL10 expression in pulmonary tuberculosis. Hum Immunol .2017;78(5-6):430-434.
1540. Kumar NP, K adar M, Dolla C, Kumaran P, Babu S. Prediabetes is associated with the modulation of antigen-specific Th1/Tc1 and Th17/Tc17 responses in latent Mycobacterium tuberculosis infection. PLoS One. 2017;12(5):e0178000.
1541. Harishankar M, Selvaraj P. Influence of Cdx2 and TaqI gene variants on vitamin D3 modulated intracellular chemokine positive T-cell subsets in pulmonary tuberculosis. Clin Ther.2017; 39(5):946-957.
1542. Vidya Vijayan KK , Karthigeyan KP, Tripathi SP, Hanna LE. Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 Infections. Front Immunol. 2017;8:580
1543. Padmapriyadarsini C, Ramesh K, Sekar L, Ramachandran G, Devaraj R, Narendran G, Sekar S, Chandrasekar C, Anbarasu D, Wanke C, Swaminathan S. Factors affecting high-density lipoprotein cholesterol in HIV-infected patients on nevirapine-based antiretroviral therapy. Indian J Med Res.2017;145:641-650.
1544. Thomas B, Closson EF, Biello K, Menon S, Navakodi P, Dhanalakshmi A, Mayer KH, Safren SA, Mimiaga MJ. Development and open pilot trial of an HIV-prevention intervention integrating mobile-phone technology for male s ex workers in Chennai, India. Arch Sex Behav.2017; 46(4): 1035–1046.
1545. Manson AL, Abeel T, Galagan JE, Sundaramurthi JC, Salazar A, Gehrmann T, Sivakumar S , Kannan P, Narayanan S , Swaminathan S , Earl AM . Mycobacterium tuberculosis whole genome sequences from southern India suggest novel resistance mechanisms and the need for region-specific diagnostics. Clin Infect Dis. 2017;64 (11):1494-1501.
1546. Suzana S, Sivakumar S, Uma Devi KR , Swarna Latha PN, Michael JS. Spoligotyping of Mycobacterium tuberculosis isolates at a tertiary care hospital in India. Trop Med Int Health .2017;22(6):703-707.
1547. Brindha S, Vincent S, Velmurugan D, Ananthakrishnan D, Sundaramurthi JC, Gnanadoss JJ. Bioinformatics approach to prirotize drugs towards repurposing for tuberculosis. Medical Hypothesis.2017;103:39-45.
1548. Bock CN , Babu S , Breloer M , A nuradha R, Yukthi B, Brunn ML , Kühl AA , Merle R , Löhning M , Hartmann S , Rausch S . Th2/1 hybrid cells occurring in murine and human strongyloidiasis share effector functions of Th1 cells. Front Cell Infect Microbiol .2017;7:261.
1549. Devi NP, Kumar AMV. Chinnakali P, Rajendran M, Vasan AS, Rewari BB, Swaminathan S. Loss to follow-up among children in pre-ART care under the National AIDS Programme, Tamil Nadu, south India. Public Health Action.2017;7(2):90-94.
1550. Unissa A N, Hanna LE . Molecular mechanisms of action, resistance, detection to the first-line anti tuberculosis drugs: Rifampicin and pyrazinamide in the post whole genome sequencing era. Tuberculosis.2017;105:96-107.
1551. Santhi D, Raja A . Dihydrolipoamide dehydrogenase-Lpd (Rv0462)-specific T cell recall responses are higher in healthy household contacts of TB: a novel immunodominant antigen from M. tuberculosis . J Leukoc Biol.2017;102(1):135-151.
1552. Unissa AN , Sukumar S , Hanna LE . The role of N-Acetyl transferases on Isoniazid resistance from Mycobacterium tuberculosis and human: An i n silico approach. Tuberc Respir Dis (Seoul).2017;80(3):255-264.
1553. Bhat J, Rao VG, Sharma RK, Muniyandi M, Yadav R, Bhondley MK. Investigation of the risk factors for pulmonary tuberculosis: A case–control study among Saharia tribe in Gwalior district, Madhya Pradesh, India. Indian J Med Res.2017;146:97-104.
1554. Thomas B , Watson B, Senthil EK. Deepalakshmi A, Balaji G, Chandra S, Manogaran C, Nagarajan K, Ovung S, Jayabal L, Swaminathan S. Alcohol intervention strategy among tuberculosis patients: a pilot study from South India. Int J Tuberc Lung Dis. 2017;21(8):947-952.
1555. Ashokkumar M, Manohar N, Narayanaiah C, Vidya Vijayan KK, Hemalatha B, Tripathy SP, Hanna LE . Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection. AIDS Res Hum Retroviruses .2017;33(8):796-806.
1556. Subbaraman R , Thomas BE , S enthil S, Suresh C, Jayabal L , Lincy S , Raja AL , McFall A , Solomon SS , Mayer KH , Swaminathan S. Tuberculosis patients in an Indian mega-city: Where do they live and where are they diagnosed? PLoS One .2017; 12(8):e0183240.
1557. Gopalan BP, Mehta K, D'souza RR, Rajnala N, A K HK, Ramachandran G, Shet A. Sub-therapeutic nevirapine concentration during antiretroviral treatment initiation among children living with HIV: Implications for therapeutic drug monitoring. PLoS One .2017;12(8):e0183080.
1558. Gupta A, Pal SK, Pandey D, Fakir NA, Rathod S, Sinha D, Siva Kumar S, Sinha P, Periera M, Balgam S, Sekar G, Uma Devi KR , Anupurba S, Nema V. PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis . Ann Clin Microbiol Antimicrob .2017;16(1):56.
1559. Kumar NP , Babu S . Influence of diabetes mellitus on immunity to human tuberculosis. Immunology.2017;152(1):13-24.
1560. Vidya Vijayan KK, Anangi B, B B, T K, S H, Hanna LE. Differential codon usage pattern of HIV-1 tat gene in those with slower and faster rates of disease progression. AIDS Res Hum Retroviruses.2017;33(9):900-901.
1561. Kumar NP, Moideen K, Vijay V, Sivakumar S, Menon PA, Kornfeld H, Babu S. Heightened circulating levels of antimicrobial peptides in tuberculosis-Diabetes co-morbidity and reversal upon treatment. Plos One.2017;12(9):e0184753.
1562. Muniyandi M, Ramachandran R. Current and developing therapies for the treatment of multi drug resistant tuberculosis (MDR-TB) in India. Expert Opin Pharmacother. 2017;18(13):1301-1309.
1563. Manikandan M, Anbarasu D, Vimala A, Gopal J, Chun S. Clinical MALDI mass spectrometry for tuberculosis diagnostics: Speculating the methodological blueprint and contemplating the obligation to improvise. Trends Analyt Chem.2017;94:190-199.
1564. Sreenivas K, Kalyanaraman H, Babu S, Narayanan RB. Recombinant Brugia malayi pepsin inhibitor (rBm33) exploits host signaling events to regulate inflammatory responses associated with lymphatic filarial infections. associated with lymphatic filarial infections. Microb Pathog.2017;112:195-208.
1565. Sundaramurthi JC, Ashokkumar M, Swaminathan S, Hanna LE. HLA based selection of epitopes offers a potential window of opportunity for vaccine design against HIV. Vaccine.2017;35(42):5568-5575.
1566. Padmapriyadarsini C, Saravanan N, Ramalingam B, Tripathy S. Malnutrition: Modulator of immune responses in tuberculosis. Front Imm.2017;8(Article 1316):1-8.
1567. Ramachandran R, Muniyandi M, Iyer V, Sripriya T, Priya B, Govindarajan TG. Dilemmas in the diagnosis and treatment of intracranial tuberculomas. J Nerol Sci. 2017;381:256-264.
1568. Dolla C, Padmapriyadarsini C, Pradeep Menon A, Muniyandi M, Adinarayanan S, Sekar G, Kavitha D, Tripathy SP, Swaminathan S. Tuberculosis among the homeless in Chennai city, south India. Trans R Soc Trop Med Hyg.2017;111(10):479-481.
1569. Anuradha R, Munisankar S, Bhootra Y, Dolla C, Kumaran P, Nutman TB, Babu S. Modulation of CD4+ and CD8+ T cell function and cytokine responses in Strongyloides stercoralis infection by Interleukin-27 (IL-27) and IL-37. Infect Immun. 2017;85(11).
1570. Rajasekaran S, Anuradha R, Ramalingam B. TLR specific immune responses against helminth infections. J Parasitol Res.2017, Article ID 6865789, 1-9.
1571. Nathan AA, Dixit M, Babu S, Balakrishnan AS. Comparison and functional characterization of peripheral blood mononuclear cells isolated from filarial lymphedema and endemic normals of a south Indian population. Trop Med Int Health.2017;22(11):1414-1427.
1572. Mimiaga MJ, Thomas BE, Biello K, Johnson BE, Swaminathan S, Navakodi P, Balaguru S, Dhanalakshmi, Closson EF, Menon S, O'Cleirigh C, Mayer KH, Safren SA. A Pilot Randomized Controlled Trial of an Integrated In-person and Mobile Phone Delivered Counseling and Text Messaging Intervention to Reduce HIV Transmission Risk among Male Sex Workers in Chennai, India. AIDS and Behav. 2017;21(11):3172-3181.
1573. Nakatani Y, Opel-Reading HK, Merker M, Machado D, Andres S, Kumar SS, Moradigaravand D, Coll F, Perdigão J, Portugal I, Schön T, Nair D, Uma Devi KR, Kohl TA, Beckert P, Clark TG, Maphalala G, Khumalo D, Diel R, Klaos K, Aung HL, Cook GM, Parkhill J, Peacock SJ, Swaminathan S, Viveiros M, Niemann S, Krause KL, Köser CU. Role of Alanine Racemase mutations in Mycobacterium tuberculosis D-cycloserine resistance. Antimicrob Agents Chemother.2017;61(12).
1574. Unissa AN, Doss C GP, Kumar T, Swathi S, Lakshmi AR, Hanna LE. Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid. J Glob Antimicrob Resist.2017;11:57-67.
1575. Unissa AN, Azger D, Kumar MP, Nagarajan P, Sukumar S, Kumari VI, Lakshmi AR, Hanna LE. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India. Tuberculosis.2017;107:144-148.
1576. Shewade HD, Nair D, Klinton JS, Parmar M, Lavanya J, Murali L, Gupta V, Tripathy JP, Swaminathan S, Kumar AMV. Low pre-diagnosis attrition but high pre-treatment attrition among patients with MDR-TB: An operational research from Chennai, India.J Epidemiol Glob Health. 2017 Dec;7(4):227-233.
1577. Mave V, Kinikar A, Kagal A, Nimkar S, Koli H, Khwaja S, Bharadwaj R, Gerona R, Wen A, Ramachandran G, Kumar H, Bacchetti P, Dooley KE, Gupte N, Gupta A, Gandhi M. Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis. PLoS One:2017;12(12): e0189101.
1578. Babu S. Biomarkers for treatment monitoring in tuberculosis: A new hope. E Biomedicine.2017;26:13-14. (no abstract)
1579. Miotto P, Tessema B, Tagliani E, Chindelevitch L, Starks AM, Emerson C, Hanna D, Kim PS, Liwski R, Zignol M, Gilpin C, Niemann S, Denkinger CM, Fleming J, Warren RM, Crook D, Posey J, Gagneux S, Hoffner S, Rodrigues C, Comas I, Engelthaler DM, Murray M, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, Uma Devi KR, McNerney R, Ezewudo M, Cirillo DM, Schito M, Köser CU, Rodwell TC. A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis. Eur Respir J.2017;50(6): 1701354.